Dubermatinib | AXL inhibitor
Available Options
| Size | Price | Quantity | |
|---|---|---|---|
| 5mg | $60.00 | ||
| 25mg | $225.00 |
Dubermatinib (1341200-45-0) is a potent (IC50 = 27 nM) inhibitor of the TAM family kinase AXL.1 It displayed potent activity against the pancreatic tumor cell line PSN-1 (IC50 = 6 nM). Dubermatinib also strongly inhibited the kinases Aurora A/B, JAK2, ABL1, and CHEK1. It induced apoptosis in chronic lymphocytic leukemia (CLL) cells and acted synergistically with BTK inhibitors against CLL cells.2 It inhibited neuroblastoma cell growth and enhanced sensitivity to conventional chemotherapy.3 Dubermatinib was also active in a drug-resistant acute myeloid leukemia model4 and reduced metastasis and therapy resistance in pancreatic cancer models5.
References/Citations:
- Mollard et al. (2011), Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors; ACS Med. Chem. Lett. 2 907
- Sinha et al. (2015); Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors; Clin. Cancer Res. 21 115
- Aveic et al. (2018); TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy; Eur. J. Pharmacol. 818 435
- Jeon et al. (2020); TP-0903 is active in models of drug-resistant acute myeloid leukemia; JCI Insight 5 e140169
- Zhang et al. (2022); Axl Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer; Mol. Cancer Ther. 21 38
C24H30ClN7O2S
98% HPLC
NMR (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
Dubermatinib (1341200-45-0) is a potent (IC50 = 27 nM) inhibitor of the TAM family kinase AXL.1 It displayed potent activity against the pancreatic tumor cell line PSN-1 (IC50 = 6 nM). Dubermatinib also strongly inhibited the kinases Aurora A/B, JAK2, ABL1, and CHEK1. It induced apoptosis in chronic lymphocytic leukemia (CLL) cells and acted synergistically with BTK inhibitors against CLL cells.2 It inhibited neuroblastoma cell growth and enhanced sensitivity to conventional chemotherapy.3 Dubermatinib was also active in a drug-resistant acute myeloid leukemia model4 and reduced metastasis and therapy resistance in pancreatic cancer models5.
References/Citations:
- Mollard et al. (2011), Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors; ACS Med. Chem. Lett. 2 907
- Sinha et al. (2015); Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors; Clin. Cancer Res. 21 115
- Aveic et al. (2018); TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy; Eur. J. Pharmacol. 818 435
- Jeon et al. (2020); TP-0903 is active in models of drug-resistant acute myeloid leukemia; JCI Insight 5 e140169
- Zhang et al. (2022); Axl Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer; Mol. Cancer Ther. 21 38
Related products
-
Pomalidomide | Cereblon ubiquitination inhibitor
From $50.00CAS:19171-19-8Catalog Number:10-2768Activity:Cereblon ubiquination inhibitorChemical Name:1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline; 3-amino-N-(2,6-dioxo-3-piperidyl)phthalamideMolecular Weight:273.24Molecular Formula:C13H11N3O4Solubility:Soluble in DMSO (up to 50 mg/ml).Physical Properties:Yellow solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.Shipping Code:RT -
iCRT5 | Beta-catenin inhibitor
From $57.00CAS:18623-44-4Catalog Number:10-1371Activity:Beta-catenin inhibitorChemical Name:4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acidMolecular Weight:367.44Molecular Formula:C16H17NO5S2Solubility:Soluble in DMSO (up to 30 mg/ml)Physical Properties:Yellow solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:-20°CStability:Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.Shipping Code:RT -
ML335 | TREK-1,2 activator
From $55.00CAS:825658-06-8Catalog Number:10-3648Activity:TREK-1,2 activatorChemical Name:N-(2,4-Dichlorobenzyl)-4-(methylsulfonamido)benzamideMolecular Weight:373.25Molecular Formula:C15H14Cl2N2O3SSolubility:Soluble in DMSO (up to 50 mg/ml) or in Ethanol (up to 20 mg/ml with warming).Physical Properties:White solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 2 months.Shipping Code:RT
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
